---
title: "Understanding the Market | SCIENTECH rose nearly 10% in the afternoon, with a year-on-year increase of 29.8% in mid-term net profit, and the biodegradable occluder technology has BD potential"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/254373659.md"
description: "SCIENTECH's stock price rose nearly 10% in the afternoon, up 8.43% as of the time of writing, trading at HKD 27, with a transaction volume of HKD 27.4975 million. The company released its interim results, reporting revenue of RMB 330 million, a year-on-year increase of 32.4%; net profit of RMB 182 million, a year-on-year increase of 29.8%. CITIC Securities pointed out that the company has a comprehensive layout in the field of structural heart disease, especially possessing globally leading technology in biodegradable occluders, and is expected to promote overseas through self-sales or BD methods in the future"
datetime: "2025-08-25T06:06:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254373659.md)
  - [en](https://longbridge.com/en/news/254373659.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254373659.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/254373659.md) | [繁體中文](https://longbridge.com/zh-HK/news/254373659.md)


# Understanding the Market | SCIENTECH rose nearly 10% in the afternoon, with a year-on-year increase of 29.8% in mid-term net profit, and the biodegradable occluder technology has BD potential

According to Zhitong Finance APP, SCIENTECH (02291) rose nearly 10% in the afternoon, and as of the time of writing, it was up 8.43%, priced at HKD 27, with a transaction volume of HKD 27.4975 million.

In terms of news, SCIENTECH released its interim results, reporting revenue of RMB 330 million, a year-on-year increase of 32.4%; net profit attributable to shareholders of the parent company was RMB 182 million, a year-on-year increase of 29.8%; basic earnings per share were RMB 0.5249. As of the date of this announcement, the company has a total of 30 types of marketed occluders, heart valves, and accessory products, 4 products under registration review and preparation, and another 28 products in various stages of research and development, including occluders, heart valves, surgical accessories, and mechanical circulatory support.

CITIC Construction Investment pointed out that SCIENTECH has a comprehensive layout in the field of structural heart disease, with a product pipeline covering congenital heart occluders, cardioembolic stroke, valves, heart failure, and other areas; the valve pipeline is rich, and TAVR products have been approved for market launch; in the field of aortic and peripheral occluders, the company is developing biodegradable aortic occluders. The firm noted that the company's performance has maintained rapid growth in recent years, mainly benefiting from the volume increase of new products such as biodegradable occluders; currently, the company's biodegradable occluder technology is at a leading level globally, with independent intellectual property rights, and there is hope for overseas promotion through independent sales or business development in the future. Considering the high costs of overseas clinical research and the leading nature of the company's product technology, this series of products has strong potential for overseas license-out

### 相关股票

- [SCIENTECH (02291.HK)](https://longbridge.com/zh-CN/quote/02291.HK.md)

## 相关资讯与研究

- [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/zh-CN/news/281213207.md)
- [Trump to sign order to pay tens of thousands of DHS employees](https://longbridge.com/zh-CN/news/281556389.md)
- [Hon Hai's US Unit Buys Foxconn Assembly for $296 Million; Shares Drop 3%](https://longbridge.com/zh-CN/news/281130288.md)
- [Tesla Robotaxis Will Be Covering 70% of US Population in 2 Weeks](https://longbridge.com/zh-CN/news/281483553.md)
- [08:01 ETKidneylink Leads the Industry as #1 in Value-Based Kidney Care Savings](https://longbridge.com/zh-CN/news/281015073.md)